Genor Biopharma Holdings Limited

HKEX:6998.HK

1.65 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

202320222021202020192018
Operating Activities:
Net Income -677.496-732.42-866.306-3,036.31-523.637-288.077
Depreciation & Amortization 76.88753.67760.74550.48540.63637.181
Deferred Income Tax 0079.797184.3081.0120
Stock Based Compensation 60.9148.238123.694257.624108.09935.535
Change In Working Capital -5.49379.55728.684-218.245261.28-43.259
Accounts Receivables 9.62100-87.6820.5810.067
Inventory 7.905-4.705-22.339-7.66-1.3693.48
Accounts Payables 00087.682-0.5810
Other Working Capital -23.01984.26251.023-210.585262.649-46.739
Other Non Cash Items 120.072-26.659-50.3551,975.4232.0815.226
Operating Cash Flow -425.12-577.607-623.741-786.715-110.529-253.394
Investing Activities:
Investments In Property Plant And Equipment -1.034-12.955-71.393-98.293-27.947-29.525
Acquisitions Net 0024.9240-12.730
Purchases Of Investments 00-7,472.675000
Sales Maturities Of Investments 007,489.185000
Other Investing Activites 7.0210.015-24.3010.049-7.3540.004
Investing Cash Flow 5.987-12.94-54.26-98.244-40.677-29.521
Financing Activities:
Debt Repayment -5.936-29.7-12.488119.9810-38.549
Common Stock Issued 0.00202.7222,735.047862.911996.919
Common Stock Repurchased 0-5.13400-574.3920
Dividends Paid 000000
Other Financing Activities -0.888-22.55827.338883.353-9.976-611.439
Financing Cash Flow -6.822-57.39217.5723,738.381278.543346.931
Other Information:
Effect Of Forex Changes On Cash 2.73136.003-68.673-177.1991.0250.042
Net Change In Cash -423.224-611.936-729.1022,676.223128.36264.058
Cash At End Of Period 1,165.4811,588.7052,200.6412,929.743253.52125.158